Globus Medical (GMED) Net Equity Issued and Repurchased (2013 - 2015)

Globus Medical (GMED) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $1.3 million in Q3 2015.

• Quarterly Net Equity Issued and Repurchased rose 28.13% year-over-year to $1.3 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $6.4 million (down 28.64% YoY) and the FY2014 annual result came in at $9.7 million, up 28.89% from the prior year.
• Net Equity Issued and Repurchased retreated to $1.3 million in Q3 2015, from $1.6 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $3.9 million in Q1 2014 to a low of $885000.0 in Q1 2013.
• A 3-year average of $2.0 million and a median of $1.6 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2014 — Net Equity Issued and Repurchased surged 335.59% — and 2015, when it plunged 63.04%.
• Tracing GMED's Net Equity Issued and Repurchased over 3 years: stood at $1.3 million in 2013, then surged by 56.97% to $2.1 million in 2014, then plunged by 38.01% to $1.3 million in 2015.
• The last three Net Equity Issued and Repurchased figures came in at $1.3 million (Q3 2015), $1.6 million (Q2 2015), and $1.4 million (Q1 2015), per Business Quant data.